Palliative sequential chemoradiotherapy for pulmonary sulcus tumor: A case report
- PMID: 27900105
- PMCID: PMC5103892
- DOI: 10.3892/mco.2016.1026
Palliative sequential chemoradiotherapy for pulmonary sulcus tumor: A case report
Abstract
Pulmonary sulcus tumors are occasionally encountered in non-small-cell lung cancer (NSCLC) patients. If the patients have a good clinical condition, concurrent chemoradiotherapy is indicated. However, palliative chemotherapy and chemoradiotherapy for patients exhibiting a poor overall condition have not been reported to date. We herein report the case of a 54-year-old female patient with a pulmonary sulcus tumor, who had a poor performance status. The patient received sequential chemoradiotherapy, with no severe complications. There was no local recurrence until the time of death, 8 months after the initiation of therapy. Palliative sequential chemoradiotherapy for pulmonary sulcus NSCLC must be effective and carry low risk of complications. Palliative sequential chemoradiotherapy may be considered in certain patients with pulmonary sulcus NSCLC. Either chemotherapy or radiotherapy is administered first and, if there is no apparent deterioration of the patient's general condition, the next treatment modality is administered.
Keywords: pulmonary sulcus tumor; sequential chemoradiotherapy.
Figures
Similar articles
-
[Analysis of preoperative concurrent chemoradiotherapy in the treatment of patients with superior sulcus tumor of the lung].Zhongguo Fei Ai Za Zhi. 2007 Feb 20;10(1):37-9. doi: 10.3779/j.issn.1009-3419.2007.01.09. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21110931 Chinese.
-
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601342 Free PMC article. Clinical Trial.
-
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):216-21. doi: 10.3760/cma.j.issn.0253-3766.2012.03.013. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780978 Chinese.
-
Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.Hematol Oncol Clin North Am. 2004 Feb;18(1):41-53. doi: 10.1016/s0889-8588(03)00138-2. Hematol Oncol Clin North Am. 2004. PMID: 15005280 Review.
-
Radical Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: When Should Concurrent Chemoradiotherapy Not Be Used?Clin Oncol (R Coll Radiol). 2016 Nov;28(11):708-711. doi: 10.1016/j.clon.2016.07.011. Epub 2016 Aug 9. Clin Oncol (R Coll Radiol). 2016. PMID: 27519158 Review.
References
-
- Xu P, Le Pechoux C. Chemoradiotherapy for stage III non-small cell lung cancer: Have we reached the limit? Chin Clin Oncol. 2015;4:45. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources